Search CORE

215 research outputs found

Transient Receptor Potential Channels as Drug Targets: From the Science of Basic Research to the Art of Medicine

Author: Abd-Elmeguid
Amaral
Andrè
Armero
Arpad Szallasi
Bai
Barquist
Bell
Bende
Bernd Nilius
Bevan
Boudes
Boychuk
Buckley
Camacho
Cameron-Smith
Carreño
Catalán
Cayouette
Cernak
Charrua
Chavez
Chhabra
Colsoul
Cruz
Cui
David R. Sibley
Delmas
Derry
Duncan
Eberle
Etherton
Fan
Foronjy
Freichel
Fujimura
Gees
Glamočlija
Golovina
Güler
Hara
Hartung
He
Hermosura
Ho
Hoffmann
Holzer
Huang
Ito
Juszczak
Kawada
Keh
Killock
Kim
Kumar
Lacroix
Laurito
Lee
Leibiger
Madisch
Marabini
Mason
McCafferty
McGarvey
Melnyk
Morelli
Nakagawa
Nakamura
Nassini
Nativi
Neeb
Nishimura
Nishimura
Noto
Okumus
Ozawa
Paltser
Patterson
Pecze
Peppin
Rasmus
Remadevi
Ritter
Rogers
Sadeh
Su
Szallasi
Szallasi
Szallasi
Szolcsànyi
Takahashi
Thorneloe
Trost
Tsavaler
van der Wijst
Vander Jagt
Vergarajauregui
Voets
Wang
Wanner
Weil
Wood
Wälti
Xu
Yao
Yun
Zhang
Publication venue: 'American Society for Pharmacology & Experimental Therapeutics (ASPET)'
Publication date
Field of study

Early ICI uptake on PET predicts response

Author: David Killock
Publication venue: Springer Science and Business Media LLC
Publication date: 16/11/2021
Field of study

SHINE a light: frontline ibrutinib for MCL

Author: David Killock
Publication venue: Springer Science and Business Media LLC
Publication date: 24/06/2022
Field of study

Anti-PD-1 therapy in the frontline

Author: David Killock
Publication venue: Springer Science and Business Media LLC
Publication date: 25/10/2016
Field of study

Camrelizumab efficacious in NPC

Author: David Killock
Publication venue: Springer Science and Business Media LLC
Publication date: 12/07/2021
Field of study

Menin–KMT2A interaction inhibitor shows promise

Author: David Killock
Publication venue: Springer Science and Business Media LLC
Publication date: 29/03/2023
Field of study

Engaging results with glofitamab in DLBCL

Author: David Killock
Publication venue: Springer Science and Business Media LLC
Publication date: 04/01/2023
Field of study

An attractive cell-therapy approach

Author: David Killock
Publication venue: Springer Science and Business Media LLC
Publication date: 08/09/2015
Field of study

Neoadjuvant PD-1 blockade in NSCLC

Author: David Killock
Publication venue: Springer Science and Business Media LLC
Publication date: 26/04/2018
Field of study

New CAPSTONE of SCLC therapy?

Author: David Killock
Publication venue: Springer Science and Business Media LLC
Publication date: 31/05/2022
Field of study

…

core